Laminin inhibits amyloid-beta-peptide fibrillation

Neurosci Lett. 1996 Nov 8;218(3):201-3. doi: 10.1016/s0304-3940(96)13147-5.

Abstract

Laminin, an important extracellular matrix component is induced by brain injury and colocalizes with amyloid-beta-peptide (A beta) deposits in Alzheimer brains. We report here that laminin inhibits amyloid fibril formation as determined by thioflavin T fluorescence spectroscopy and electron microscopic examination. The inhibition of amyloid formation by laminin was concentration dependent and was observed at a laminin concentration of 300 nM, corresponding to a laminin/A beta protein molar ratio of 1:800. The potential effect of laminin, may prove important to inhibit A beta fibrillogenesis in vivo, specifically at the level of cerebral blood vessels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / drug effects*
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Peptides / ultrastructure
  • Humans
  • Laminin / pharmacology*
  • Microscopy, Electron
  • Neurofibrillary Tangles / chemistry

Substances

  • Amyloid beta-Peptides
  • Laminin